Article de revue
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
BCG vaccination provides incomplete protection against tuberculosis in infants. A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was designed to enhance the protective efficacy of BCG. The study aimed to assess safety, immunogenicity, and efficacy of MVA85A against tuberculosis and Mycobacterium tuberculosis infection in infants.
Auteurs
Langues
- Anglais
Année de publication
2013
Journal
Lancet
Volume
9871
Type
Article de revue
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Tuberculose
Pays
- Afrique du Sud
Mots-clés
- Suivi de la couverture
- Introduction de nouveaux vaccins
Régions de l'OMS
- Région africaine